Table 1 Baseline characteristics of patients with neurological symptoms after vaccinating inactivated COVID-19 vaccine
From: Inactivated COVID-19 vaccine induced acute stroke-like focal neurologic symptoms: a case series
Characteristics | n = 19 |
|---|---|
Age, year, mean (SD) | 34 (7.5) |
Gender, Female | 17 (89.5) |
Underlying disease | 7 (36.8) |
Allergic rhinitis | 2 (10.5) |
Skin allergy | 1 (5.2) |
Asthma | 1 (5.2) |
Polycystic ovary syndrome | 1 (5.2) |
Chocolate cyst | 1 (5.2) |
Systemic lupus erythematosus | 1(5.2) |
Associated trigger | |
Caffeine | 8 (42.1) |
Vasoconstrictive drugs | 0 |
Contraceptive medications | 3 (15.8) |
Prior headache disorders | 9 (47%) |
Smoking | 1 (5.2) |
Recreational drug use | 0 |
Drug allergic reaction | 3 (15.8) |
Psychiatric disorders including panic, hyperventilation and anxiety | 0 |
History of food allergy | 1 (5.2) |
Body mass index, mean (SD) | 21.3 (2.5) |
Systolic Blood pressure, mmHg, mean (SD) | 123.5 (9.8) |
Diastolic Blood pressure, mmHg, mean (SD) | 73.4 (10.6) |
Heart rate, beat per minute, mean (SD) | 89.8 (13.2) |